Published Date：Mar.2021
Industry：Chemical & Material
Pages：109 Table Number：127
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Gadolinium-based Contrast Agent market in this environment. In terms of revenue, this research report indicated that the global Gadolinium-based Contrast Agent market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Gadolinium-based Contrast Agent industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The GE Healthcare aims at producing XX Gadolinium-based Contrast Agent in 2020, with XX % production to take place in global market, Bayer HealthCare accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Gadolinium-based Contrast Agent Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Gadolinium-based Contrast Agent Market? GE Healthcare Bayer HealthCare Guerbet Bracco Diagnostic Lantheus Medical Imaging ... Major Type of Gadolinium-based Contrast Agent Covered in XYZResearch report: Linear non-ionic agent Linear ionic Macrocyclic non-ionic Macrocyclic ionic Application Segments Covered in XYZResearch Market Hospitals Specialty clinics Diagnostic centers Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Gadolinium-based Contrast Agent Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Linear non-ionic agent -Product Introduction and Major Manufacturers 1.1.2 Linear ionic -Product Introduction and Major Manufacturers 1.1.3 Macrocyclic non-ionic -Product Introduction and Major Manufacturers 1.1.4 Macrocyclic ionic -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Gadolinium-based Contrast Agent Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Gadolinium-based Contrast Agent Market 3.1.1 Top Companies leading Gadolinium-based Contrast Agent Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Gadolinium-based Contrast Agent Market 3.2.1 Top Companies leading Gadolinium-based Contrast Agent Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Gadolinium-based Contrast Agent Market 3.3.1 Top Companies leading Gadolinium-based Contrast Agent Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Gadolinium-based Contrast Agent Market 3.4.1 Top Companies leading Gadolinium-based Contrast Agent Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Gadolinium-based Contrast Agent Market 3.5.1 Top Companies leading Gadolinium-based Contrast Agent Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Gadolinium-based Contrast Agent Market 3.6.1 Top Companies leading Gadolinium-based Contrast Agent Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Gadolinium-based Contrast Agent Market 3.7.1 Top Companies leading Gadolinium-based Contrast Agent Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Gadolinium-based Contrast Agent Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Gadolinium-based Contrast Agent Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Gadolinium-based Contrast Agent Sales and Growth Rate (2021-2026) 5.2 Global Gadolinium-based Contrast Agent Sales Value and Growth Rate (2021-2026) 6 Gadolinium-based Contrast Agent Competitive Analysis 6.1 GE Healthcare 6.1.1 GE Healthcare Company Profiles 6.1.2 GE Healthcare Product Introduction 6.1.3 GE Healthcare Gadolinium-based Contrast Agent Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Bayer HealthCare 6.2.1 Bayer HealthCare Company Profiles 6.2.2 Bayer HealthCare Product Introduction 6.2.3 Bayer HealthCare Gadolinium-based Contrast Agent Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Guerbet 6.3.1 Guerbet Company Profiles 6.3.2 Guerbet Product Introduction 6.3.3 Guerbet Gadolinium-based Contrast Agent Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Bracco Diagnostic 6.4.1 Bracco Diagnostic Company Profiles 6.4.2 Bracco Diagnostic Product Introduction 6.4.3 Bracco Diagnostic Gadolinium-based Contrast Agent Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Lantheus Medical Imaging 6.5.1 Lantheus Medical Imaging Company Profiles 6.5.2 Lantheus Medical Imaging Product Introduction 6.5.3 Lantheus Medical Imaging Gadolinium-based Contrast Agent Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Gadolinium-based Contrast Agent Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Gadolinium-based Contrast Agent Sales (K Unit) by Type (2015-2026) Figure Global Gadolinium-based Contrast Agent Sales (K Unit) and Growth Rate (2015-2026) Figure Global Gadolinium-based Contrast Agent Sales Market Share (%) by Type (2019 -2020) Table Global Gadolinium-based Contrast Agent Sales Value (Million USD) by Type (2015-2026) Figure Global Gadolinium-based Contrast Agent Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Gadolinium-based Contrast Agent Sales Value Market Share (%) by Type (2019-2020) Table Global Gadolinium-based Contrast Agent Sales (K Unit) by Application (2015-2026) Table China Gadolinium-based Contrast Agent Sales (K Unit) of Major Company (2015-2020) Table China Gadolinium-based Contrast Agent Sales Market Share of Major Company (2015-2020) Table China Gadolinium-based Contrast Agent Sales Value (Million USD) of Major Company (2015-2020) Figure China Gadolinium-based Contrast Agent Sales Value (Million USD) and Growth Rate (2015-2020) Table China Gadolinium-based Contrast Agent Sales Value Share of Major Company (2015-2020) Table China Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) Table China Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Figure China Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Table EU Gadolinium-based Contrast Agent Sales (K Unit) of Major Company (2015-2020) Table EU Gadolinium-based Contrast Agent Sales Market Share of Major Company (2015-2020) Table EU Gadolinium-based Contrast Agent Sales Value (Million USD) of Major Company (2015-2020) Figure EU Gadolinium-based Contrast Agent Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Gadolinium-based Contrast Agent Sales Value Share of Major Company (2015-2020) Table EU Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) Table EU Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Figure EU Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Table USA Gadolinium-based Contrast Agent Sales (K Unit) of Major Company (2015-2020) Table USA Gadolinium-based Contrast Agent Sales Market Share of Major Company (2015-2020) Table USA Gadolinium-based Contrast Agent Sales Value (Million USD) of Major Company (2015-2020) Figure USA Gadolinium-based Contrast Agent Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Gadolinium-based Contrast Agent Sales Value Share of Major Company (2015-2020) Table USA Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) Table USA Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Figure USA Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Table Japan Gadolinium-based Contrast Agent Sales (K Unit) of Major Company (2015-2020) Table Japan Gadolinium-based Contrast Agent Sales Market Share of Major Company (2015-2020) Table Japan Gadolinium-based Contrast Agent Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Gadolinium-based Contrast Agent Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Gadolinium-based Contrast Agent Sales Value Share of Major Company (2015-2020) Table Japan Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) Table Japan Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Figure Japan Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Table India Gadolinium-based Contrast Agent Sales (K Unit) of Major Company (2015-2020) Table India Gadolinium-based Contrast Agent Sales Market Share of Major Company (2015-2020) Table India Gadolinium-based Contrast Agent Sales Value (Million USD) of Major Company (2015-2020) Figure India Gadolinium-based Contrast Agent Sales Value (Million USD) and Growth Rate (2015-2020) Table India Gadolinium-based Contrast Agent Sales Value Share of Major Company (2015-2020) Table India Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) Table India Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Figure India Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Table Southeast Asia Gadolinium-based Contrast Agent Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Gadolinium-based Contrast Agent Sales Market Share of Major Company (2015-2020) Table Southeast Asia Gadolinium-based Contrast Agent Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Gadolinium-based Contrast Agent Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Gadolinium-based Contrast Agent Sales Value Share of Major Company (2015-2020) Table Southeast Asia Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Figure Southeast Asia Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Table South America Gadolinium-based Contrast Agent Sales (K Unit) of Major Company (2015-2020) Table South America Gadolinium-based Contrast Agent Sales Market Share of Major Company (2015-2020) Table South America Gadolinium-based Contrast Agent Sales Value (Million USD) of Major Company (2015-2020) Figure South America Gadolinium-based Contrast Agent Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Gadolinium-based Contrast Agent Sales Value Share of Major Company (2015-2020) Table South America Gadolinium-based Contrast Agent Price (USD/Unit), by Type (2019-2020) Table South America Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Figure South America Gadolinium-based Contrast Agent Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Gadolinium-based Contrast Agent Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Gadolinium-based Contrast Agent Figure Cost Structure of Gadolinium-based Contrast Agent in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Gadolinium-based Contrast Agent Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Gadolinium-based Contrast Agent Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table GE Healthcare Profiles Table GE Healthcare Gadolinium-based Contrast Agent Product Introduction Table GE Healthcare Gadolinium-based Contrast Agent Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure GE Healthcare SWOT Analysis Table Bayer HealthCare Profiles Table Bayer HealthCare Gadolinium-based Contrast Agent Product Introduction Table Bayer HealthCare Gadolinium-based Contrast Agent Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Bayer HealthCare SWOT Analysis Table Guerbet Profiles Table Guerbet Gadolinium-based Contrast Agent Product Introduction Table Guerbet Gadolinium-based Contrast Agent Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Guerbet SWOT Analysis Table Bracco Diagnostic Profiles Table Bracco Diagnostic Gadolinium-based Contrast Agent Product Introduction Table Bracco Diagnostic Gadolinium-based Contrast Agent Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Bracco Diagnostic SWOT Analysis Table Lantheus Medical Imaging Profiles Table Lantheus Medical Imaging Gadolinium-based Contrast Agent Product Introduction Table Lantheus Medical Imaging Gadolinium-based Contrast Agent Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
